Source: Annual Congress 2002 - Isolated lung perfusion and lung cancer
Disease area: Thoracic oncology

Abstract

48 patients with NSCLC and ipsilateral pleural effusion underwent thoracotomy between 1990 and 1999. Hystological types were squamous cell carcinoma in 23 cases (0,48) and adenocarcinoma in 25 cases (0,52). In 35 patients (0,71) effusion was found by roentgenogram and CT of the chest, without evidence of carcinomatosis by pleural fluid cytology. Effusion in remaining 13 cases (0,29) was found at thoracotomy.
In time of thoracotomy pleural metastases were diagnosed in 19 patients (0,40), there were surgically unresectable. From other 29 patients with paramalignant effusion 9 (0,31) were unresectable owing to mediastinal vessels involvement. 20 patients only undergone complete resection of tumor: 16 in stage IIIa (0,8) and 4 in stage IIIb (0,2). 15 pneumonectomies (0,75) and 5 lobectomies (0,25) were done. 2- and 5-year survival was 0,39 and 0,17.
The presence of a pleural effusion in lung cancer patients associated with poor prognosis. The number patients with paramalignant pleural effusion can be treated surgically.

Rating:

Share or cite this content

Citations should be made in the following way:
A. Akopov, G. Varlamova (St-Petersburg, Russia). Surgery for lung cancer with pleural effusion. Eur Respir J 2002; 20: Suppl. 38, 1154

Member's Comments

No comment yet.

Related content which might interest you: Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Malignant pericardial effusion in lung cancer patients Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions Year: 2006 Diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules Year: 2007 Pleural effusion in lung cancer and targeted therapy Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Medical thoracoscopy for diagnosis of pleural effusion in cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003 Lung cancer and pleural mesothelioma Source: Eur Respir Monogr 2014; 65: 48-60 Year: 2014 Epidemiology and clinical problems of orphant pleural adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Pleural effusion in cases of breast carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 What outcome after pleurodesis in malignant pleural effusion in lung cancer? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019